Understanding and modeling metastasis biology to improve therapeutic strategies for combating osteosarcoma progression
TM Fan, RD Roberts, MM Lizardo - Frontiers in oncology, 2020 - frontiersin.org
Osteosarcoma is a malignant primary tumor of bone, arising from transformed progenitor
cells with osteoblastic differentiation and osteoid production. While categorized as a rare …
cells with osteoblastic differentiation and osteoid production. While categorized as a rare …
Metastatic progression of osteosarcomas: a review of current knowledge of environmental versus oncogenic drivers
GA Odri, J Tchicaya-Bouanga, DJY Yoon, D Modrowski - Cancers, 2022 - mdpi.com
Simple Summary Osteosarcomas are heterogeneous bone tumors with complex genetic and
chromosomic alterations. The numerous patients with metastatic osteosarcoma have a very …
chromosomic alterations. The numerous patients with metastatic osteosarcoma have a very …
Present advances and future perspectives of molecular targeted therapy for osteosarcoma
Osteosarcoma (OS) is a bone cancer mostly occurring in pediatric population. Current
treatment regime of surgery and intensive chemotherapy could cure about 60%–75 …
treatment regime of surgery and intensive chemotherapy could cure about 60%–75 …
Osteosarcoma: accelerating progress makes for a hopeful future
AJ Saraf, JM Fenger, RD Roberts - Frontiers in oncology, 2018 - frontiersin.org
Patients who develop osteosarcoma in 2017 receive treatment that remains essentially
unchanged since the 1970s. Outcomes likewise remain largely unimproved. Large …
unchanged since the 1970s. Outcomes likewise remain largely unimproved. Large …
Toward a drug development path that targets metastatic progression in osteosarcoma
C Khanna, TM Fan, R Gorlick, LJ Helman… - Clinical Cancer …, 2014 - AACR
Despite successful primary tumor treatment, the development of pulmonary metastasis
continues to be the most common cause of mortality in patients with osteosarcoma. A …
continues to be the most common cause of mortality in patients with osteosarcoma. A …
Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis
M Li, X Jin, H Li, G Wu, S Wang, C Yang, S Deng - BMC cancer, 2020 - Springer
Background Osteosarcoma is a primary malignant tumor originating from mesenchymal
tissue, with a poor distant metastasis prognosis. The molecular mechanisms of …
tissue, with a poor distant metastasis prognosis. The molecular mechanisms of …
Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy
J Zhao, DC Dean, FJ Hornicek, X Yu, Z Duan - Cancer letters, 2020 - Elsevier
Osteosarcoma (OS) is the most common primary bone malignancy and is frequently lethal
via metastasis to the lung. While surgical techniques and adjuvant chemotherapies have …
via metastasis to the lung. While surgical techniques and adjuvant chemotherapies have …
Animal models of bone metastasis
JK Simmons, BE Hildreth III, W Supsavhad… - Veterinary …, 2015 - journals.sagepub.com
Bone is one of the most common sites of cancer metastasis in humans and is a significant
source of morbidity and mortality. Bone metastases are considered incurable and result in …
source of morbidity and mortality. Bone metastases are considered incurable and result in …
Understanding the biology of bone sarcoma from early initiating events through late events in metastasis and disease progression
L Zhu, MM McManus, DPM Hughes - Frontiers in oncology, 2013 - frontiersin.org
The two most common primary bone malignancies, osteosarcoma (OS), and Ewing sarcoma
(ES), are both aggressive, highly metastatic cancers that most often strike teens, though both …
(ES), are both aggressive, highly metastatic cancers that most often strike teens, though both …